Searching News Database: drug eluting stent
HSMN NewsFeed - 24 Apr 2024
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO
HSMN NewsFeed - 27 Oct 2021
HT Supreme(R) Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
HT Supreme(R) Drug Eluting Stent performs equivalent to best-in-class in the PIONEER III publication
HSMN NewsFeed - 23 May 2018
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
Newest Generation of Leading Heart Stent is Now Approved in the U.S. for People with Coronary Artery Disease
HSMN NewsFeed - 25 Jul 2017
Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.
Roxwood Medical Announces Agreement with Abbott for Distribution of Products in U.S.
HSMN NewsFeed - 26 Apr 2017
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
Mercator MedSystems Announces First Enrollment in the TANGO Trial for BTK Vascular Disease
HSMN NewsFeed - 21 Nov 2016
OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing
OrbusNeich Introduces a New Generation COMBO Plus Dual Therapy Stent for Active Healing
HSMN NewsFeed - 16 Mar 2016
Abbott's Absorb(TM), the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
Abbott's Absorb(TM), the First Fully Dissolving Heart Stent, Earns Positive Review by FDA Advisory Committee
HSMN NewsFeed - 15 Dec 2015
Svelte Medical Systems Announces CE Mark Certification of SLENDER IDS(TM)
Svelte Medical Systems Announces CE Mark Certification of SLENDER IDS(TM)
HSMN NewsFeed - 12 Oct 2015
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
Abbott Announces Positive Clinical Results of Absorb(TM), the Naturally Dissolving Heart Stent
HSMN NewsFeed - 5 Oct 2015
Boston Scientific Receives FDA Approval For SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System
Boston Scientific Receives FDA Approval For SYNERGY(TM) Bioabsorbable Polymer Drug-Eluting Stent System
HSMN NewsFeed - 19 May 2015
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
Abbott Announces CE Mark for New Advancement of Absorb Stent System for People with Heart Disease
HSMN NewsFeed - 18 Sep 2014
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
Latest Data Shows OrbusNeich's COMBO(TM) Dual Therapy Stent has Excellent Healing Benefits
HSMN NewsFeed - 15 Aug 2014
Cook Medical Enrolls First Patient in Zilver(R) PTX(R) Drug Eluting Peripheral Stent Clinical Study in China
Cook Medical Enrolls First Patient in Zilver(R) PTX(R) Drug Eluting Peripheral Stent Clinical Study in China
HSMN NewsFeed - 5 Jun 2014
Cook Medical Makes Zilver(R) PTX(R) Drug-Eluting Stent Available in Canada
Cook Medical Makes Zilver(R) PTX(R) Drug-Eluting Stent Available in Canada
HSMN NewsFeed - 23 May 2014
OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
OrbusNeich Releases Long-term Data for World's First and Only Dual Therapy Stent
HSMN NewsFeed - 21 May 2014
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
Boston Scientific Reports Strong Performance Data For SYNERGY(TM) Stent System
HSMN NewsFeed - 20 May 2014
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patients
HSMN NewsFeed - 14 Nov 2013
Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study
Svelte Medical Systems Announces Enrollment Complete in the DIRECT II Drug-Eluting Stent Study
HSMN NewsFeed - 25 Oct 2013
Abbott's First-In-Class MitraClip(R) Device Now Available for U.S. Patients
Abbott's First-In-Class MitraClip(R) Device Now Available for U.S. Patients
HSMN NewsFeed - 15 Jul 2013
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
Abbott to Acquire IDEV Technologies to Expand Global Peripheral Technology Portfolio
HSMN NewsFeed - 10 Jul 2013
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
Abbott Announces Approval of Next-Generation XIENCE Xpedition(TM) Drug Eluting Stent System in Japan
HSMN NewsFeed - 30 Jan 2013
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
Svelte Medical Systems Announces Treatment of First Patient in the DIRECT II Drug-Eluting Stent Study
HSMN NewsFeed - 21 Jan 2013
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
OrbusNeich's COMBO Dual Therapy Stent(TM) to Be Featured During AsiaPCR/SingLIVE 2013 Symposium
HSMN NewsFeed - 26 Nov 2012
Tryton Medical Announces Completion of Patient Enrollment in Landmark Pivotal Study of Side Branch Stent
Tryton Medical Announces Completion of Patient Enrollment in Landmark Pivotal Study of Side Branch Stent
HSMN NewsFeed - 11 Oct 2012
Cook Medical’s Zilver(R) PTX(R) Trial Shows Sustained Patency after Three Years
Cook Medical’s Zilver(R) PTX(R) Trial Shows Sustained Patency after Three Years
HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
HSMN NewsFeed - 20 Aug 2012
Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent
Abbott Announces CE Mark and European Launch of Next-Generation XIENCE Xpedition™ Drug Eluting Stent
HSMN NewsFeed - 25 May 2012
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
Medtronic Resolute(R) Stent Shows Strong Performance in Heart Disease Patients With and Without Diabetes
HSMN NewsFeed - 21 May 2012
Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD)
Cook Medical Launches First Drug-Eluting Stent in Australia to Treat Peripheral Arterial Disease (PAD)
HSMN NewsFeed - 15 May 2012
Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study
Svelte Medical Systems Announces Final Patient Treated in the DIRECT Drug-Eluting Stent Study
HSMN NewsFeed - 9 Apr 2012
Abbott Receives Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in Japan
Abbott Receives Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in Japan
HSMN NewsFeed - 22 Mar 2012
OrbusNeich's Genous(TM) Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
OrbusNeich's Genous(TM) Technology Effectively Promotes Endothelialization and Reduces Thrombogenicity
HSMN NewsFeed - 9 Mar 2012
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
Biosensors Makes Organizational Changes to Senior Management Team to Prepare for Continued Growth
HSMN NewsFeed - 1 Mar 2012
Cook Medical Receives Japanese Approval to Market Its Zilver(R) PTX(R) Drug-Eluting Stent
Cook Medical Receives Japanese Approval to Market Its Zilver(R) PTX(R) Drug-Eluting Stent
HSMN NewsFeed - 1 Mar 2012
Boston Scientific Announces Launch of PROMUS Element(TM) Platinum Chromium Stent System in Japan
Boston Scientific Announces Launch of PROMUS Element(TM) Platinum Chromium Stent System in Japan
HSMN NewsFeed - 1 Nov 2011
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
Abbott Receives U.S. FDA Approval for Next-Generation XIENCE PRIME(TM) Drug Eluting Stent
HSMN NewsFeed - 15 Jun 2011
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
Johnson & Johnson Announces Special Charge Related to Restructuring Plans for Cordis Corporation Subsidiary
HSMN NewsFeed - 15 Jun 2011
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
Cordis Announces Discontinuation of NEVO Sirolimus-Eluting Coronary Stent
HSMN NewsFeed - 8 Jun 2011
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
Boston Scientific Announces Favorable Appellate Court Ruling Affirming Invalidity of J&J Patents
HSMN NewsFeed - 23 May 2011
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
Elixir Medical Receives CE Mark for DESyne(TM) Novolimus Eluting Coronary Stent System
HSMN NewsFeed - 18 May 2011
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
Medtronic Resolute(R) Drug-Eluting Stent Offers Strong Performance in Diabetic Patients with Heart Disease
HSMN NewsFeed - 25 Apr 2011
Boston Scientific Announces FDA Approval and U.S. Launch of ION Platinum Chromium Stent System
Boston Scientific Announces FDA Approval and U.S. Launch of ION Platinum Chromium Stent System
HSMN NewsFeed - 28 Mar 2011
Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11
Medtronic to Unveil Pivotal U.S. Data on Resolute(R) Drug-Eluting Stent at ACC.11
HSMN NewsFeed - 17 Feb 2011
Boston Scientific Launches PROMUS(R) Element and TAXUS(R) Element Stent Systems in India
Boston Scientific Launches PROMUS(R) Element and TAXUS(R) Element Stent Systems in India
HSMN NewsFeed - 26 Jan 2011
Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent
Tryton Announces Enrollment of First U.S. Patient in Pivotal Study of Side Branch Stent
HSMN NewsFeed - 20 Dec 2010
Tryton Announces Enrollment of First Patient in U.S. Pivotal Study of Side Branch Stent
Tryton Announces Enrollment of First Patient in U.S. Pivotal Study of Side Branch Stent
HSMN NewsFeed - 29 Oct 2010
Tryton Presents Positive Six-Month Results for Side Branch Stent System at European Bifurcation Club Meeting
Tryton Presents Positive Six-Month Results for Side Branch Stent System at European Bifurcation Club Meeting
HSMN NewsFeed - 22 Sep 2010
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
Abbott's Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
HSMN NewsFeed - 22 Sep 2010
Boston Scientific's TAXUS(R) Element Stent Demonstrates Strong Outcomes in Diabetic Patients
Boston Scientific's TAXUS(R) Element Stent Demonstrates Strong Outcomes in Diabetic Patients
HSMN NewsFeed - 22 Sep 2010
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
Long-Term Data Show Advantages for TAXUS(R) Liberte(R) Stent in Small Vessels and Long Lesions
HSMN NewsFeed - 22 Sep 2010
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
Medtronic's Resolute Drug-Eluting Stent Shows Strong Performance in Second 'All Comers' Study
HSMN NewsFeed - 21 Sep 2010
PROMUS(R) Element Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
PROMUS(R) Element Stent Approved for Use in Diabetic and Heart Attack Patients in CE Mark Countries
HSMN NewsFeed - 7 Sep 2010
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
Medtronic Announces First European Implant of New Drug-eluting Stent at Southampton General Hospital, UK
HSMN NewsFeed - 31 Aug 2010
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
CORDIS Announces Results of Ten-Year CYPHER(R) Sirolimus-Eluting Coronary Stent Follow-Up
HSMN NewsFeed - 26 May 2010
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
Boston Scientific Begins PLATINUM PLUS Trial for PROMUS(R) Element(TM) Stent System
HSMN NewsFeed - 25 May 2010
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
Abbott's Groundbreaking Bioresorbable Technology Continues to Demonstrate Exceptional Clinical Results
HSMN NewsFeed - 25 May 2010
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
Medtronic's Resolute(R) Drug-Eluting Stent Matches Market-Leading Rival in Large Head-to-Head Study
HSMN NewsFeed - 12 May 2010
Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System
Boston Scientific Announces European Approval of Platinum Chromium TAXUS(R) Element(TM) Stent System
HSMN NewsFeed - 16 Mar 2010
Boston Scientific Completes Enrollment in PLATINUM Trials for Small Vessels and Long Lesions
Boston Scientific Completes Enrollment in PLATINUM Trials for Small Vessels and Long Lesions
HSMN NewsFeed - 15 Feb 2010
Stentys Drug-Eluting Self-Expanding Coronary Stent Shows 4% Restenosis in Complex Lesions
Stentys Drug-Eluting Self-Expanding Coronary Stent Shows 4% Restenosis in Complex Lesions
HSMN NewsFeed - 29 Jan 2010
Invatec Comments on First Clinical Results of Drug Eluting Balloon Technology for Below the Knee (BtK)
Invatec Comments on First Clinical Results of Drug Eluting Balloon Technology for Below the Knee (BtK)
HSMN NewsFeed - 8 Jan 2010
Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System
Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System
HSMN NewsFeed - 23 Sep 2009
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
Abbott's XIENCE V(R) Superior to TAXUS(R) in Key Safety and Efficacy Measures in SPIRIT IV Trial
HSMN NewsFeed - 23 Sep 2009
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry
InspireMD Announces the Enrollment of the 1st Patient in the MGuard(TM) Israeli Registry
HSMN NewsFeed - 18 Sep 2009
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Boston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
HSMN NewsFeed - 14 Sep 2009
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
Abbott Announces Approval in China for Next-Generation XIENCE V(R) Drug Eluting Stent
HSMN NewsFeed - 31 Aug 2009
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
Abbott Launches Next-Generation XIENCE PRIME(TM) Drug Eluting Stent in International Markets
HSMN NewsFeed - 11 Aug 2009
Breakthrough Drug-Eluting Stent to Treat Peripheral Arterial Disease Now Available in Europe
Breakthrough Drug-Eluting Stent to Treat Peripheral Arterial Disease Now Available in Europe
HSMN NewsFeed - 27 Jul 2009
Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
Medtronic and Abbott Laboratories Resolve Global Vascular Patent Disputes
HSMN NewsFeed - 27 May 2009
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
FDA Approves Boston Scientific's Next-Generation TAXUS(R) Liberte(R) Atom(TM) Stent System
HSMN NewsFeed - 19 May 2009
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent
HSMN NewsFeed - 19 May 2009
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
Endeavor Drug-Eluting Stent is First to Receive CE Mark for Treating Acute Coronary Syndrome
HSMN NewsFeed - 19 May 2009
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
Invatec Officially Launches Coronary Drug-Eluting Balloon Platform IN.PACT Falcon at EuroPCR
HSMN NewsFeed - 14 May 2009
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
Medtronic Completes Enrollment in International Post-Market Study of Resolute Drug-Eluting Stent
HSMN NewsFeed - 22 Apr 2009
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
OrbusNeich's Genous(TM) Bio-engineered R stent(TM) Demonstrates Impressive Results in Higher Risk Patients
HSMN NewsFeed - 1 Apr 2009
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
Abbott Initiates U.S. Study of Absolute Pro(TM) Peripheral Stent System for Iliac Artery Disease
HSMN NewsFeed - 31 Mar 2009
TYRX Announces the Appointment of George D. Landau as Vice President, Business Development
TYRX Announces the Appointment of George D. Landau as Vice President, Business Development
HSMN NewsFeed - 30 Mar 2009
Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent in Japan
Medtronic Receives Regulatory Approval For Endeavor Drug-Eluting Coronary Stent in Japan
HSMN NewsFeed - 19 Mar 2009
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
XTENT Receives CE Mark Approval for CUSTOM NX (R) Drug-Eluting Stent System
HSMN NewsFeed - 12 Mar 2009
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent
HSMN NewsFeed - 3 Mar 2009
Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
Boston Scientific Announces Japanese Launch of Taxus(R) Liberte(R) Drug-Eluting Stent System
HSMN NewsFeed - 18 Feb 2009
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
New England Journal of Medicine Publishes Results from Boston Scientific's Landmark SYNTAX(TM) Trial
HSMN NewsFeed - 5 Feb 2009
Hospitals, Healthcare Providers to Save with New Premier Drug Eluting Coronary Stents Agreements
Hospitals, Healthcare Providers to Save with New Premier Drug Eluting Coronary Stents Agreements
HSMN NewsFeed - 4 Feb 2009
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
Boston Scientific Begins Clinical Trial Enrollment for New Everolimus-Eluting Stent
HSMN NewsFeed - 28 Jan 2009
Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
Boston Scientific Announces Japanese Approval for TAXUS(R) Liberte(R) Drug-Eluting Stent System
HSMN NewsFeed - 26 Jan 2009
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
Circulation Publishes Pivotal Two-Year Results On XIENCE V(TM) Drug Eluting Stent
HSMN NewsFeed - 17 Dec 2008
Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
Abbott Begins U.S. Study of XIENCE V(TM) Drug Eluting Stent Designed for Small Vessels
HSMN NewsFeed - 24 Nov 2008
Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President
Terumo Heart Announces Appointment of William Pinon to Chief Executive Officer and President
HSMN NewsFeed - 12 Nov 2008
Medtronic Launches Endeavor® Sprint Drug-Eluting Stent System on Rapid Exchange in United States
Medtronic Launches Endeavor® Sprint Drug-Eluting Stent System on Rapid Exchange in United States
HSMN NewsFeed - 30 Oct 2008
SurModics Licenses Hydrophilic Coating for Elixir's Drug-Eluting and Bare Metal Stent Delivery Systems
SurModics Licenses Hydrophilic Coating for Elixir's Drug-Eluting and Bare Metal Stent Delivery Systems
HSMN NewsFeed - 14 Oct 2008
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter
HSMN NewsFeed - 12 Oct 2008
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
Taxus Atlas Studies Reinforce Safety and Efficacy of Boston Scientific's Next-Generation Taxus Liberte Stent
HSMN NewsFeed - 10 Oct 2008
Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
Boston Scientific Announces FDA Approval of Second-Generation TAXUS(R) Liberte(R) Drug-Eluting Stent
HSMN NewsFeed - 8 Oct 2008
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
Boston Scientific Completes Clinical Trial Enrollment for Third-Generation Drug-Eluting Stent
HSMN NewsFeed - 26 Sep 2008
Tryton Medical Announces European Launch of Stent System for Bifurcation Lesions
Tryton Medical Announces European Launch of Stent System for Bifurcation Lesions
HSMN NewsFeed - 15 Sep 2008
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
Medtronic Starts U.S. and International Trials of Endeavor(R) Resolute Drug-Eluting Coronary Stent
HSMN NewsFeed - 15 Sep 2008
Tryton Medical Announces Two Key Hires and Relocation to Research Triangle Park, N.C.
Tryton Medical Announces Two Key Hires and Relocation to Research Triangle Park, N.C.
HSMN NewsFeed - 1 Sep 2008
SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
SCAI: SYNTAX Data Show PCI Is a Good Option for Patients With Complex Coronary Artery Disease
HSMN NewsFeed - 30 Jul 2008
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
Medtronic Starts U.S. Arm of Global Study Comparing Safety of Endeavor(R) and Cypher(R) Drug-Eluting Stents
HSMN NewsFeed - 20 Jun 2008
XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
XTENT Appoints Christopher M. Smith and Arthur T. Taylor to Board of Directors
HSMN NewsFeed - 29 May 2008
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
Drug-Eluting Coronary Stents Utilizing Isotechnika's Lead Drug Receive Approval to Enter Clinical Trials
HSMN NewsFeed - 20 May 2008
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
MIV's Stents Subject of Two Live Cases and Several Presentations at EuroPCR
HSMN NewsFeed - 13 May 2008
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
HSMN NewsFeed - 17 Apr 2008
Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
Boston Scientific Receives Canadian Approval for TAXUS(R) Liberte(R) Stent System
HSMN NewsFeed - 1 Apr 2008
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
Study Finds Taxus(R) Drug-Eluting Stent Beneficial in Treatment of Large Vessels
HSMN NewsFeed - 31 Mar 2008
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
HSMN NewsFeed - 31 Mar 2008
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
Spirit II Results Support Strength of Boston Scientific's Two Drug-Eluting Stent Platforms
HSMN NewsFeed - 29 Mar 2008
Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
Real-World Data from ARRIVE Registries Show Favorable Outcomes for TAXUS(R) Express(TM) Stent
HSMN NewsFeed - 19 Mar 2008
Bifurcated Stent Company Stentys Completes $18 Million 'Series B' Venture Financing
Bifurcated Stent Company Stentys Completes $18 Million 'Series B' Venture Financing
HSMN NewsFeed - 11 Feb 2008
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
Boston Scientific Announces Start of Major European Registry Assessing Different Olimus-Eluting Stents
HSMN NewsFeed - 1 Feb 2008
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
Medtronic Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System
HSMN NewsFeed - 31 Jan 2008
Stentys bifurcated stent is successfully implanted for the first time at the Rotterdam ThoraxCenter
Stentys bifurcated stent is successfully implanted for the first time at the Rotterdam ThoraxCenter
HSMN NewsFeed - 18 Jan 2008
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
Biosensors Receives CE Mark Approval for Its BioMatrix(R) Drug-Eluting Coronary Stent System
HSMN NewsFeed - 7 Jan 2008
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
MIV Therapeutics Appoints Mark Landy to Additional Post of Chief Executive Officer
HSMN NewsFeed - 27 Dec 2007
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
HSMN NewsFeed - 21 Dec 2007
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
TAXUS(R) Liberte(TM) Drug-eluting Coronary Stent System Receives CE Mark for Use in Diabetic Patients
HSMN NewsFeed - 13 Dec 2007
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
PCI Guideline Update Stresses Long-Term Anticoagulant Therapy After Treatment With Drug-Eluting Stents
HSMN NewsFeed - 29 Nov 2007
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
FDA Advisory Committee Recommends Approval of Abbott's XIENCE(TM) V Drug Eluting Stent System
HSMN NewsFeed - 5 Nov 2007
Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29
Abbott Confirms FDA Advisory Panel to Review XIENCE(TM) V Drug Eluting Stent on November 29
HSMN NewsFeed - 24 Oct 2007
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
Safety Profile of Medtronic's Endeavor(R) Drug-Eluting Stent Affirmed in Comprehensive Data Analysis
HSMN NewsFeed - 23 Oct 2007
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
Adoption of Drug-Eluting Stents Associated with Lower Health Care Costs and Improved Clinical Outcomes
HSMN NewsFeed - 22 Oct 2007
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
Positive Five-Year Safety Data for TAXUS(R) Stent Reported in Boston Scientific Trial
HSMN NewsFeed - 22 Oct 2007
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
Boston Scientific's Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions
HSMN NewsFeed - 22 Oct 2007
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
Boston Scientific PROMUS(TM) and TAXUS(R) Stents Continue Strong Performance in Safety and Efficacy Measures
HSMN NewsFeed - 22 Oct 2007
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
Endeavor Clinical Program Continues to Provide Positive Safety and Efficacy Data
HSMN NewsFeed - 22 Oct 2007
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
Elixir Medical Announces Positive Clinical Results for the Company's First Drug Eluting Coronary Stent
HSMN NewsFeed - 22 Oct 2007
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
MIV Therapeutics Announces Positive Results From First Human Study With Its VESTASYNC Stent
HSMN NewsFeed - 10 Oct 2007
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
FDA Advisory Committee Recommends Medtronic's Endeavor(R) Drug-Eluting Stent for Approval
HSMN NewsFeed - 5 Oct 2007
Medtronic to Present Findings from the Comprehensive ENDEAVOR Clinical Experience to FDA Advisory Panel
Medtronic to Present Findings from the Comprehensive ENDEAVOR Clinical Experience to FDA Advisory Panel
HSMN NewsFeed - 24 Sep 2007
First-in-Man Milestone Reported for the Stentys Bifurcated Drug-Eluting Stent
First-in-Man Milestone Reported for the Stentys Bifurcated Drug-Eluting Stent
HSMN NewsFeed - 13 Sep 2007
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
Largest Study to Date Finds Drug-Eluting Stents and Bare-Metal Stents Yield Similarly Low Mortality Rates
HSMN NewsFeed - 12 Sep 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent on October 10
HSMN NewsFeed - 5 Sep 2007
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
HSMN NewsFeed - 2 Sep 2007
Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry
Safety Profile of TAXUS(R) Liberte(TM) Stent System Highlighted in World's Largest Stent Registry
HSMN NewsFeed - 21 Aug 2007
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent in October
FDA Advisory Panel to Review Medtronic's Endeavor Drug Eluting Stent in October
HSMN NewsFeed - 1 Jun 2007
Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
Abbott Submits XIENCE(TM) V Everolimus Eluting Coronary Stent System Application for U.S. FDA Approval
HSMN NewsFeed - 23 May 2007
Efficacy of OrbusNeich's Genous(TM) Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
Efficacy of OrbusNeich's Genous(TM) Bio-Engineered R Stent Compares Favorably to Drug-Eluting Stents
HSMN NewsFeed - 22 May 2007
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
XTENT Announces Promising Six-Month Custom II Trial Data Presented at EuroPCR Meeting
HSMN NewsFeed - 22 May 2007
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
ARRIVE Registry Analysis Identifies Predictors of Stent Thrombosis in Real-World Use of Drug-Eluting Stents
HSMN NewsFeed - 21 May 2007
Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
Medtronic Announces Start of 8,800-Patient Clinical Trial Evaluating Drug-Eluting Stent Safety
HSMN NewsFeed - 7 May 2007
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
Conor Medsystems, LLC Reports COSTAR II Pivotal Drug-Eluting Stent Trial Conclusions
HSMN NewsFeed - 1 May 2007
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
Daniel J. Moore Appointed President and Chief Executive Officer of Cyberonics
HSMN NewsFeed - 16 Apr 2007
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
COURAGE, SPIRIT Data May Support Role of Advanced Imaging and Diagnosis With IVUS and FFR
HSMN NewsFeed - 4 Apr 2007
Volcano Corporation Reports Use of IVUS Increasing as Physicians Refocus on Stent Technique
Volcano Corporation Reports Use of IVUS Increasing as Physicians Refocus on Stent Technique
HSMN NewsFeed - 3 Apr 2007
Boston Scientific Announces Japanese Approval for the TAXUS(R) Express2(TM) Stent System
Boston Scientific Announces Japanese Approval for the TAXUS(R) Express2(TM) Stent System
HSMN NewsFeed - 26 Mar 2007
Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stent's Positive Clinical Profile
Two-Year Results from the Medtronic ENDEAVOR III Trial Confirm Stent's Positive Clinical Profile
HSMN NewsFeed - 23 Mar 2007
Boston Scientific Announces Industry-Leading Program to Improve Anti-Platelet Compliance for DES Patients
Boston Scientific Announces Industry-Leading Program to Improve Anti-Platelet Compliance for DES Patients
HSMN NewsFeed - 5 Mar 2007
Boston Scientific to Provide Information to House Committee on Oversight and Government Reform
Boston Scientific to Provide Information to House Committee on Oversight and Government Reform
HSMN NewsFeed - 5 Mar 2007
AGA Medical Appoints Jack Darby as Vice President Worldwide Sales and Marketing
AGA Medical Appoints Jack Darby as Vice President Worldwide Sales and Marketing
HSMN NewsFeed - 12 Feb 2007
Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents
Boston Scientific Welcomes New England Journal of Medicine Articles on Drug-Eluting Stents
HSMN NewsFeed - 5 Feb 2007
Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes
Study Favors Drug-Eluting Stents Over Bare-Metal Stents in Key Patient Outcomes
HSMN NewsFeed - 30 Jan 2007
First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
First International Trial of Drug-Eluting Peripheral Artery Stent Results Encouraging
HSMN NewsFeed - 11 Jan 2007
Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in Europe
Private-Label Version of Abbott's XIENCE(TM)V Drug-Eluting Coronary Stent System Launches in Europe
HSMN NewsFeed - 11 Jan 2007
Boston Scientific Announces First Use of PROMUS(TM) Everolimus-Eluting Stent System
Boston Scientific Announces First Use of PROMUS(TM) Everolimus-Eluting Stent System
HSMN NewsFeed - 4 Jan 2007
French Court Rules in Favor of evYsio Medical Devices in Patent Litigation Against Abbott Laboratories
French Court Rules in Favor of evYsio Medical Devices in Patent Litigation Against Abbott Laboratories
HSMN NewsFeed - 20 Dec 2006
Implant Sciences' Strategic Partner Receives CE Mark for Its Valecor(TM) Coronary Stent System
Implant Sciences' Strategic Partner Receives CE Mark for Its Valecor(TM) Coronary Stent System
HSMN NewsFeed - 5 Dec 2006
American Heart Association Statement on Use of Drug-Eluting Coronary Stents
American Heart Association Statement on Use of Drug-Eluting Coronary Stents
HSMN NewsFeed - 29 Nov 2006
Cleveland Clinic Analysis Finds Patients With Drug-Eluting Stents Are at Increased Risk for Late Thrombosis
Cleveland Clinic Analysis Finds Patients With Drug-Eluting Stents Are at Increased Risk for Late Thrombosis
HSMN NewsFeed - 17 Nov 2006
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
SurModics Provides Additional Information on its License Agreement with Conor Medsystems
HSMN NewsFeed - 16 Nov 2006
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
Johnson & Johnson Announces Definitive Agreement to Acquire Conor Medsystems, Inc.
HSMN NewsFeed - 16 Nov 2006
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System
Medtronic Submits Final PMA Modules to FDA for Approval of the Endeavor Drug-Eluting Coronary Stent System
HSMN NewsFeed - 14 Nov 2006
Study Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients
Study Favors TAXUS(R) Stent Over Cypher(R) Stent and Bare-Metal Stents in Diabetic Patients
HSMN NewsFeed - 27 Oct 2006
MIV Therapeutics Announces Timeline for First Human Implantation of HAp NanoFilm Coated Stent
MIV Therapeutics Announces Timeline for First Human Implantation of HAp NanoFilm Coated Stent
HSMN NewsFeed - 26 Oct 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
TAXUS(R) stents demonstrate excellent efficacy and safety in studies presented at TCT 2006
HSMN NewsFeed - 25 Oct 2006
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
Medtronic Announces Positive Results for Endeavor RESOLUTE Drug-Eluting Coronary Stent System
HSMN NewsFeed - 25 Oct 2006
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months
Safety and Efficacy Benefits of Next-Generation TAXUS(R) Liberte(TM) Stent Sustained at Twelve Months
HSMN NewsFeed - 22 Oct 2006
TAXUS(R) Performance Superior to Cypher(R) in Diabetic Patients in Head-to-Head Study
TAXUS(R) Performance Superior to Cypher(R) in Diabetic Patients in Head-to-Head Study
HSMN NewsFeed - 20 Oct 2006
Volcano Corporation and MediGuide Ltd. Announce Collaboration for Advanced Imaging and Navigation Technology
Volcano Corporation and MediGuide Ltd. Announce Collaboration for Advanced Imaging and Navigation Technology
HSMN NewsFeed - 19 Oct 2006
Medtronic Announces Key Activities at Transcatheter Cardiovascular Therapeutics (TCT) Meeting
Medtronic Announces Key Activities at Transcatheter Cardiovascular Therapeutics (TCT) Meeting
HSMN NewsFeed - 19 Oct 2006
Medtronic Announces Largest Clinical Study Evaluating Drug-Eluting Stent Safety
Medtronic Announces Largest Clinical Study Evaluating Drug-Eluting Stent Safety
HSMN NewsFeed - 11 Oct 2006
Volcano Announces First Permanent Installations of the Integrated s5i IVUS Imaging System
Volcano Announces First Permanent Installations of the Integrated s5i IVUS Imaging System
HSMN NewsFeed - 5 Oct 2006
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
Conor Medsystems Receives Approval for One-Year Shelf Life for CoStar(R) Stent in the European Union
HSMN NewsFeed - 4 Oct 2006
Medtronic Announces Regulatory Approval for the Endeavor Drug-Eluting Coronary Stent System in Australia
Medtronic Announces Regulatory Approval for the Endeavor Drug-Eluting Coronary Stent System in Australia
HSMN NewsFeed - 3 Oct 2006
Abbott Begins Early International Launch of XIENCE(TM) V Everolimus Eluting Coronary Stent System
Abbott Begins Early International Launch of XIENCE(TM) V Everolimus Eluting Coronary Stent System
HSMN NewsFeed - 7 Sep 2006
SurModics and X-Cell Medical Collaborate on Drug Eluting Stent Development
SurModics and X-Cell Medical Collaborate on Drug Eluting Stent Development
HSMN NewsFeed - 6 Sep 2006
TAXUS II Clinical Trial Follow-Up Data Demonstrates Excellent Long-Term Outcomes at Four Years
TAXUS II Clinical Trial Follow-Up Data Demonstrates Excellent Long-Term Outcomes at Four Years
HSMN NewsFeed - 27 Jun 2006
Medtronic Announces Completion of Patient Enrollment in ENDEAVOR IV Clinical Trial
Medtronic Announces Completion of Patient Enrollment in ENDEAVOR IV Clinical Trial
HSMN NewsFeed - 22 Jun 2006
Cordis Corporation's Third-Generation Coronary Stent Approved for Use in Europe
Cordis Corporation's Third-Generation Coronary Stent Approved for Use in Europe
HSMN NewsFeed - 18 May 2006
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
Conor Medsystems Announces First Patient Treated with Dual-Drug Coronary Stent
HSMN NewsFeed - 18 May 2006
Endeavor Registry Data Confirms High Deliverability Success and Broad, Everyday Use by Physicians
Endeavor Registry Data Confirms High Deliverability Success and Broad, Everyday Use by Physicians
HSMN NewsFeed - 17 May 2006
TAXUS(R) coronary stent system cited by EuroIntervention for superiority in diabetic patients
TAXUS(R) coronary stent system cited by EuroIntervention for superiority in diabetic patients
HSMN NewsFeed - 17 May 2006
Cordis Corporation Submits Pre-Market Approval Supplement for Direct Stenting
Cordis Corporation Submits Pre-Market Approval Supplement for Direct Stenting
HSMN NewsFeed - 17 May 2006
TAXUS(R) Coronary Stent System Cited by EuroIntervention for Superiority in Diabetic Patients
TAXUS(R) Coronary Stent System Cited by EuroIntervention for Superiority in Diabetic Patients
HSMN NewsFeed - 16 May 2006
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
Xtent CUSTOM I Trial Shows Zero Restenosis, Favorable Late Loss Results at Eight Months
HSMN NewsFeed - 16 May 2006
TAXUS ATLAS Trial Supports Superior Deliverability and Proven Outcomes of TAXUS(R) Liberte(TM) Stent System
TAXUS ATLAS Trial Supports Superior Deliverability and Proven Outcomes of TAXUS(R) Liberte(TM) Stent System
HSMN NewsFeed - 16 May 2006
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
X-Cell Medical Completes Enrollment for Clinical Trial of ETHOS II Estradiol Eluting Stent
HSMN NewsFeed - 16 May 2006
TAXUS(R) Liberte(TM) Stent System Receives European Approval for Three Complex Coronary Procedures
TAXUS(R) Liberte(TM) Stent System Receives European Approval for Three Complex Coronary Procedures
HSMN NewsFeed - 15 May 2006
SurModics Provides Hydrophilic Coating on Xtent's Drug-Eluting Stent Delivery System
SurModics Provides Hydrophilic Coating on Xtent's Drug-Eluting Stent Delivery System
HSMN NewsFeed - 15 May 2006
Abbott Announces First Patients Enrolled in ZOMAXX(TM) EUROPE Clinical Trial
Abbott Announces First Patients Enrolled in ZOMAXX(TM) EUROPE Clinical Trial
HSMN NewsFeed - 12 May 2006
Tryton Announces First Clinical Use of its Side-Branch Stent (TM) to Treat Coronary Bifurcation Lesions
Tryton Announces First Clinical Use of its Side-Branch Stent (TM) to Treat Coronary Bifurcation Lesions
HSMN NewsFeed - 11 May 2006
Cordis Corporation Submits Pre-Market Approval Submission for Reblockage in Coronary Stent
Cordis Corporation Submits Pre-Market Approval Submission for Reblockage in Coronary Stent
HSMN NewsFeed - 11 May 2006
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Conor Medsystems Initiates RAPID Clinical Study for First Pimecrolimus Drug-Eluting Stent
Additional items found! 312
Members Archive contains
312 additional stories matching:
drug eluting stent
(Password required)
drug eluting stent
(Password required)